[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Prophylactic Pediatric Vaccines Market Research Report Forecast 2017-2021

April 2017 | 103 pages | ID: E0CF6A21C36EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe Prophylactic Pediatric Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prophylactic Pediatric Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prophylactic Pediatric Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs

Europe Prophylactic Pediatric Vaccines Market Analysis by Countries :
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)

Europe Prophylactic Pediatric Vaccines Market Analysis by Product :
Type 1
Type 2
Type 3

Europe Prophylactic Pediatric Vaccines Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
1 PROPHYLACTIC PEDIATRIC VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Pediatric Vaccines
1.2 Classification of Prophylactic Pediatric Vaccines
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Prophylactic Pediatric Vaccines
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prophylactic Pediatric Vaccines Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Prophylactic Pediatric Vaccines (2012-2021)
  1.5.1 Europe Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2021)
  1.5.2 Europe Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON PROPHYLACTIC PEDIATRIC VACCINES INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 PROPHYLACTIC PEDIATRIC VACCINES MANUFACTURING COST ANALYSIS

3.1 Prophylactic Pediatric Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Prophylactic Pediatric Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Prophylactic Pediatric Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Prophylactic Pediatric Vaccines Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE PROPHYLACTIC PEDIATRIC VACCINES MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Prophylactic Pediatric Vaccines Market Competition by Manufacturers
  5.1.1 Europe Prophylactic Pediatric Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Prophylactic Pediatric Vaccines Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Prophylactic Pediatric Vaccines (Volume and Value) by Type
  5.2.1 Europe Prophylactic Pediatric Vaccines Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Prophylactic Pediatric Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Europe Prophylactic Pediatric Vaccines (Volume and Value) by Countries
  5.3.1 Europe Prophylactic Pediatric Vaccines Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Prophylactic Pediatric Vaccines Revenue and Market Share by Countries (2012-2017)
5.4 Europe Prophylactic Pediatric Vaccines (Volume) by Application

6 GERMANY PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  6.1.1 Germany Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Germany Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
6.2 Germany Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
6.3 Germany Prophylactic Pediatric Vaccines Sales and Market Share by Type
6.4 Germany Prophylactic Pediatric Vaccines Sales and Market Share by Application

7 FRANCE PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 France Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  7.1.1 France Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 France Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 France Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
7.2 France Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
7.3 France Prophylactic Pediatric Vaccines Sales and Market Share by Type
7.4 France Prophylactic Pediatric Vaccines Sales and Market Share by Application

8 UK PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 UK Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  8.1.1 UK Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 UK Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 UK Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
8.2 UK Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
8.3 UK Prophylactic Pediatric Vaccines Sales and Market Share by Type
8.4 UK Prophylactic Pediatric Vaccines Sales and Market Share by Application

9 RUSSIA PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  9.1.1 Russia Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Russia Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
9.2 Russia Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
9.3 Russia Prophylactic Pediatric Vaccines Sales and Market Share by Type
9.4 Russia Prophylactic Pediatric Vaccines Sales and Market Share by Application

10 ITALY PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  10.1.1 Italy Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  10.1.2 Italy Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
10.2 Italy Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
10.3 Italy Prophylactic Pediatric Vaccines Sales and Market Share by Type
10.4 Italy Prophylactic Pediatric Vaccines Sales and Market Share by Application

11 SPAIN PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  11.1.1 Spain Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  11.1.2 Spain Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
11.2 Spain Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
11.3 Spain Prophylactic Pediatric Vaccines Sales and Market Share by Type
11.4 Spain Prophylactic Pediatric Vaccines Sales and Market Share by Application

12 BENELUX PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  12.1.1 Benelux Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
12.2 Benelux Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
12.3 Benelux Prophylactic Pediatric Vaccines Sales and Market Share by Type
12.4 Benelux Prophylactic Pediatric Vaccines Sales and Market Share by Application

13 EUROPE PROPHYLACTIC PEDIATRIC VACCINES MANUFACTURERS ANALYSIS

13.1 ALK - Abello A/S (Denmark)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Altimmune, Inc. (US)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Bavarian Nordic A/S (Denmark)
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 BiondVax Pharmaceuticals Ltd. (Israel)
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Bharat Biotech International Limited (India)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 GlaxoSmithKline Plc. (UK)
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Hualan Biological Engineering Inc. (China)
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Janssen Pharmaceuticals, Inc. (US)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 MedImmune (US)
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE PROPHYLACTIC PEDIATRIC VACCINES MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Prophylactic Pediatric Vaccines Market Forecast by Type (2017-2021)
15.9 Europe Prophylactic Pediatric Vaccines Market Forecast by Application (2017-2021)

16 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Pediatric Vaccines
Table Classification of Prophylactic Pediatric Vaccines
Figure Europe Sales Market Share of Prophylactic Pediatric Vaccines by Type in 2015
Table Application of Prophylactic Pediatric Vaccines
Figure Europe Sales Market Share of Prophylactic Pediatric Vaccines by Application in 2015
Figure Germany Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure France Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure UK Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Russia Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Italy Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Spain Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Benelux Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Europe Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2021)
Figure Europe Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Table Europe Prophylactic Pediatric Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Prophylactic Pediatric Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Pediatric Vaccines Sales Share by Manufacturers
Figure 2016 Prophylactic Pediatric Vaccines Sales Share by Manufacturers
Table Europe Prophylactic Pediatric Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Prophylactic Pediatric Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Prophylactic Pediatric Vaccines Revenue Share by Manufacturers
Table 2016 Europe Prophylactic Pediatric Vaccines Revenue Share by Manufacturers
Table Europe Prophylactic Pediatric Vaccines Sales and Market Share by Type (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Prophylactic Pediatric Vaccines by Type (2012-2017)
Figure Europe Prophylactic Pediatric Vaccines Sales Growth Rate by Type (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Revenue and Market Share by Type (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Pediatric Vaccines by Type (2012-2017)
Figure Europe Prophylactic Pediatric Vaccines Revenue Growth Rate by Type (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales and Market Share by Countries (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales Share by Countries (2012-2017)
Figure Sales Market Share of Prophylactic Pediatric Vaccines by Countries (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Revenue and Market Share by Countries (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Prophylactic Pediatric Vaccines by Countries (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales and Market Share by Application (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Prophylactic Pediatric Vaccines by Application (2012-2017)
Figure Germany Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure Germany Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure Germany Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table Germany Prophylactic Pediatric Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Prophylactic Pediatric Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Prophylactic Pediatric Vaccines Sales by Type (2015 and 2016)
Table Germany Prophylactic Pediatric Vaccines Market Share by Type (2015 and 2016)
Table Germany Prophylactic Pediatric Vaccines Sales by Application (2015 and 2016)
Table Germany Prophylactic Pediatric Vaccines Market Share by Application (2015 and 2016)
Figure France Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure France Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure France Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table France Prophylactic Pediatric Vaccines Sales by Manufacturers (2015 and 2016)
Table France Prophylactic Pediatric Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Prophylactic Pediatric Vaccines Sales by Type (2015 and 2016)
Table France Prophylactic Pediatric Vaccines Market Share by Type (2015 and 2016)
Table France Prophylactic Pediatric Vaccines Sales by Application (2015 and 2016)
Table France Prophylactic Pediatric Vaccines Market Share by Application (2015 and 2016)
Figure UK Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure UK Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure UK Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table UK Prophylactic Pediatric Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Prophylactic Pediatric Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Prophylactic Pediatric Vaccines Sales by Type (2015 and 2016)
Table UK Prophylactic Pediatric Vaccines Market Share by Type (2015 and 2016)
Table UK Prophylactic Pediatric Vaccines Sales by Application (2015 and 2016)
Table UK Prophylactic Pediatric Vaccines Market Share by Application (2015 and 2016)
Figure Russia Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure Russia Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure Russia Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table Russia Prophylactic Pediatric Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Prophylactic Pediatric Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Prophylactic Pediatric Vaccines Sales by Type (2015 and 2016)
Table Russia Prophylactic Pediatric Vaccines Market Share by Type (2015 and 2016)
Table Russia Prophylactic Pediatric Vaccines Sales by Application (2015 and 2016)
Table Russia Prophylactic Pediatric Vaccines Market Share by Application (2015 and 2016)
Figure Italy Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure Italy Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure Italy Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table Italy Prophylactic Pediatric Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Prophylactic Pediatric Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Prophylactic Pediatric Vaccines Sales by Type (2015 and 2016)
Table Italy Prophylactic Pediatric Vaccines Market Share by Type (2015 and 2016)
Table Italy Prophylactic Pediatric Vaccines Sales by Application (2015 and 2016)
Table Italy Prophylactic Pediatric Vaccines Market Share by Application (2015 and 2016)
Figure Spain Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure Spain Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure Spain Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table Spain Prophylactic Pediatric Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Prophylactic Pediatric Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Prophylactic Pediatric Vaccines Sales by Type (2015 and 2016)
Table Spain Prophylactic Pediatric Vaccines Market Share by Type (2015 and 2016)
Table Spain Prophylactic Pediatric Vaccines Sales by Application (2015 and 2016)
Table Spain Prophylactic Pediatric Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure Benelux Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure Benelux Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table Benelux Prophylactic Pediatric Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Prophylactic Pediatric Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Prophylactic Pediatric Vaccines Sales by Type (2015 and 2016)
Table Benelux Prophylactic Pediatric Vaccines Market Share by Type (2015 and 2016)
Table Benelux Prophylactic Pediatric Vaccines Sales by Application (2015 and 2016)
Table Benelux Prophylactic Pediatric Vaccines Market Share by Application (2015 and 2016)
Table ALK - Abello A/S (Denmark) Basic Information List
Table ALK - Abello A/S (Denmark) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure ALK - Abello A/S (Denmark) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table Altimmune, Inc. (US) Basic Information List
Table Altimmune, Inc. (US) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Altimmune, Inc. (US) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table Bavarian Nordic A/S (Denmark) Basic Information List
Table Bavarian Nordic A/S (Denmark) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S (Denmark) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List
Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table Bharat Biotech International Limited (India) Basic Information List
Table Bharat Biotech International Limited (India) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bharat Biotech International Limited (India) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc. (UK) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table Hualan Biological Engineering Inc. (China) Basic Information List
Table Hualan Biological Engineering Inc. (China) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Inc. (China) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information List
Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017)
Table MedImmune (US) Basic Information List
Table MedImmune (US) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune (US) Prophylactic Pediatric Vaccines Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Pediatric Vaccines
Figure Manufacturing Process Analysis of Prophylactic Pediatric Vaccines
Figure Prophylactic Pediatric Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Pediatric Vaccines Major Manufacturers in 2015
Table Major Buyers of Prophylactic Pediatric Vaccines
Table Distributors/Traders List
Figure Germany Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Germany Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure France Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure France Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure UK Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure UK Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Russia Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Italy Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Spain Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table Europe Prophylactic Pediatric Vaccines Sales Forecast by Type (2017-2021)
Table Europe Prophylactic Pediatric Vaccines Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)
Merck & Co., Inc. (US)
Pfizer Inc. (US)
Sanofi Pasteur SA (France)
Serum Institute of India Pvt. Ltd. (India)
Shanghai BravoBio Co., Ltd. (China)
Seqirus (UK)
SK Chemicals Co., Ltd. (Korea)
Takeda Pharmaceutical Company Limited (Japan)
Zydus Cadila (India)


More Publications